<?xml version='1.0' encoding='utf-8'?>
<document id="15654717"><sentence text="Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions."><entity charOffset="23-28" id="DDI-PubMed.15654717.s1.e0" text="azole" /><entity charOffset="82-93" id="DDI-PubMed.15654717.s1.e1" text="fluconazole" /><entity charOffset="88-98" id="DDI-PubMed.15654717.s1.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s1.e0" e2="DDI-PubMed.15654717.s1.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s1.e0" e2="DDI-PubMed.15654717.s1.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s1.e0" e2="DDI-PubMed.15654717.s1.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s1.e1" e2="DDI-PubMed.15654717.s1.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s1.e1" e2="DDI-PubMed.15654717.s1.e2" /></sentence><sentence text="To assess the frequency of potential azole-drug interactions and consequences of interactions between fluconazole and other drugs in routine inpatient care"><entity charOffset="37-42" id="DDI-PubMed.15654717.s2.e0" text="azole" /><entity charOffset="102-113" id="DDI-PubMed.15654717.s2.e1" text="fluconazole" /><entity charOffset="108-118" id="DDI-PubMed.15654717.s2.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s2.e0" e2="DDI-PubMed.15654717.s2.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s2.e0" e2="DDI-PubMed.15654717.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s2.e0" e2="DDI-PubMed.15654717.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s2.e1" e2="DDI-PubMed.15654717.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s2.e1" e2="DDI-PubMed.15654717.s2.e2" /></sentence><sentence text="" /><sentence text="We performed a retrospective cohort study of hospitalized patients treated for systemic fungal infections with an oral or intravenous azole medication between July 1997 and June 2001 in a tertiary care hospital"><entity charOffset="134-139" id="DDI-PubMed.15654717.s4.e0" text="azole" /></sentence><sentence text=" We recorded the concomitant use of medications known to interact with azole antifungals and measured the frequency of potential azole drug interactions, which we considered to be present when both drugs were given together"><entity charOffset="71-76" id="DDI-PubMed.15654717.s5.e0" text="azole" /><entity charOffset="129-134" id="DDI-PubMed.15654717.s5.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s5.e0" e2="DDI-PubMed.15654717.s5.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s5.e0" e2="DDI-PubMed.15654717.s5.e1" /></sentence><sentence text=" We then performed a chart review on a random sample of admissions in which patients were exposed to a potential moderate or major drug interaction with fluconazole"><entity charOffset="153-164" id="DDI-PubMed.15654717.s6.e0" text="fluconazole" /><entity charOffset="159-169" id="DDI-PubMed.15654717.s6.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s6.e0" e2="DDI-PubMed.15654717.s6.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s6.e0" e2="DDI-PubMed.15654717.s6.e1" /></sentence><sentence text=" The list of azole-interacting medications and the severity of interaction were derived from the DRUGDEX System and Drug Interaction Facts"><entity charOffset="13-18" id="DDI-PubMed.15654717.s7.e0" text="azole" /></sentence><sentence text="" /><sentence text="Among the 4,185 admissions in which azole agents (fluconazole, itraconazole or ketoconazole) were given, 2,941 (70"><entity charOffset="36-41" id="DDI-PubMed.15654717.s9.e0" text="azole" /><entity charOffset="50-61" id="DDI-PubMed.15654717.s9.e1" text="fluconazole" /><entity charOffset="63-75" id="DDI-PubMed.15654717.s9.e2" text="itraconazole" /><entity charOffset="79-91" id="DDI-PubMed.15654717.s9.e3" text="ketoconazole" /><entity charOffset="56-67" id="DDI-PubMed.15654717.s9.e4" text="azole" /><entity charOffset="70-81" id="DDI-PubMed.15654717.s9.e5" text="azole" /><entity charOffset="86-97" id="DDI-PubMed.15654717.s9.e6" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e4" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e0" e2="DDI-PubMed.15654717.s9.e6" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e4" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e1" e2="DDI-PubMed.15654717.s9.e6" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e4" e2="DDI-PubMed.15654717.s9.e4" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e4" e2="DDI-PubMed.15654717.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e4" e2="DDI-PubMed.15654717.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e4" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e4" e2="DDI-PubMed.15654717.s9.e6" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e2" e2="DDI-PubMed.15654717.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e2" e2="DDI-PubMed.15654717.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e2" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e2" e2="DDI-PubMed.15654717.s9.e6" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e5" e2="DDI-PubMed.15654717.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e5" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e5" e2="DDI-PubMed.15654717.s9.e6" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e3" e2="DDI-PubMed.15654717.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s9.e3" e2="DDI-PubMed.15654717.s9.e6" /></sentence><sentence text="3%) admissions experienced potential azole-drug interactions, which included 2,716 (92"><entity charOffset="37-42" id="DDI-PubMed.15654717.s10.e0" text="azole" /></sentence><sentence text="3%) admissions experiencing potential fluconazole interactions"><entity charOffset="38-49" id="DDI-PubMed.15654717.s11.e0" text="fluconazole" /><entity charOffset="44-54" id="DDI-PubMed.15654717.s11.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s11.e0" e2="DDI-PubMed.15654717.s11.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s11.e0" e2="DDI-PubMed.15654717.s11.e1" /></sentence><sentence text=" The most frequent interactions with potential moderate to major severity were co-administration of fluconazole with prednisone (25"><entity charOffset="100-111" id="DDI-PubMed.15654717.s12.e0" text="fluconazole" /><entity charOffset="117-127" id="DDI-PubMed.15654717.s12.e1" text="prednisone" /><entity charOffset="106-115" id="DDI-PubMed.15654717.s12.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s12.e0" e2="DDI-PubMed.15654717.s12.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s12.e0" e2="DDI-PubMed.15654717.s12.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s12.e0" e2="DDI-PubMed.15654717.s12.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s12.e2" e2="DDI-PubMed.15654717.s12.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s12.e2" e2="DDI-PubMed.15654717.s12.e1" /></sentence><sentence text="3%), midazolam (17"><entity charOffset="5-14" id="DDI-PubMed.15654717.s13.e0" text="midazolam" /></sentence><sentence text="5%), warfarin (14"><entity charOffset="5-13" id="DDI-PubMed.15654717.s14.e0" text="warfarin" /></sentence><sentence text="7%), methylprednisolone (14"><entity charOffset="5-23" id="DDI-PubMed.15654717.s15.e0" text="methylprednisolone" /></sentence><sentence text="1%), cyclosporine (10"><entity charOffset="5-17" id="DDI-PubMed.15654717.s16.e0" text="cyclosporine" /></sentence><sentence text="7%) and nifedipine (10"><entity charOffset="8-18" id="DDI-PubMed.15654717.s17.e0" text="nifedipine" /></sentence><sentence text="1%)" /><sentence text=" Charts were reviewed for 199 admissions in which patients were exposed to potential fluconazole drug interactions"><entity charOffset="85-96" id="DDI-PubMed.15654717.s19.e0" text="fluconazole" /><entity charOffset="91-101" id="DDI-PubMed.15654717.s19.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s19.e0" e2="DDI-PubMed.15654717.s19.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s19.e0" e2="DDI-PubMed.15654717.s19.e1" /></sentence><sentence text=" While four adverse drug events (ADEs) caused by fluconazole were found, none was felt to be caused by a drug-drug interaction (DDI), although in one instance fluconazole may have contributed"><entity charOffset="49-60" id="DDI-PubMed.15654717.s20.e0" text="fluconazole" /><entity charOffset="159-170" id="DDI-PubMed.15654717.s20.e1" text="fluconazole" /><entity charOffset="55-65" id="DDI-PubMed.15654717.s20.e2" text="azole" /><entity charOffset="165-175" id="DDI-PubMed.15654717.s20.e3" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e0" e2="DDI-PubMed.15654717.s20.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e0" e2="DDI-PubMed.15654717.s20.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e0" e2="DDI-PubMed.15654717.s20.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e0" e2="DDI-PubMed.15654717.s20.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e2" e2="DDI-PubMed.15654717.s20.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e2" e2="DDI-PubMed.15654717.s20.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e2" e2="DDI-PubMed.15654717.s20.e3" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e1" e2="DDI-PubMed.15654717.s20.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s20.e1" e2="DDI-PubMed.15654717.s20.e3" /></sentence><sentence text="" /><sentence text="Potential fluconazole drug interactions were very frequent among hospitalized patients on systemic azole antifungal therapy, but they had few apparent clinical consequences"><entity charOffset="10-21" id="DDI-PubMed.15654717.s22.e0" text="fluconazole" /><entity charOffset="99-104" id="DDI-PubMed.15654717.s22.e1" text="azole" /><entity charOffset="16-20" id="DDI-PubMed.15654717.s22.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.15654717.s22.e0" e2="DDI-PubMed.15654717.s22.e0" /><pair ddi="false" e1="DDI-PubMed.15654717.s22.e0" e2="DDI-PubMed.15654717.s22.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s22.e0" e2="DDI-PubMed.15654717.s22.e1" /><pair ddi="false" e1="DDI-PubMed.15654717.s22.e2" e2="DDI-PubMed.15654717.s22.e2" /><pair ddi="false" e1="DDI-PubMed.15654717.s22.e2" e2="DDI-PubMed.15654717.s22.e1" /></sentence><sentence text="" /></document>